Telomerase reverse transcriptase promoter methylation is related to a risk of recurrence in hepatocellular carcinoma
- PMID: 25847141
- DOI: 10.1002/hep.27833
Telomerase reverse transcriptase promoter methylation is related to a risk of recurrence in hepatocellular carcinoma
Comment in
-
Reply.Hepatology. 2016 Jan;63(1):342. doi: 10.1002/hep.27827. Epub 2015 Jun 3. Hepatology. 2016. PMID: 25846279 No abstract available.
Comment on
-
Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.Hepatology. 2014 Dec;60(6):1983-92. doi: 10.1002/hep.27372. Epub 2014 Oct 27. Hepatology. 2014. PMID: 25123086
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
